Life Science Nation Newsletter  |  October 2, 2014  |  Issue 82

  The LSN Story   |   Investor Platform   |   Company Platform   |   RESI Conference   |   Fundraising Accelerator
In This Issue

Major Corporate Venture Funds Discuss Early Stage Investing

How to Identify Life Science Investors


Life Science Investors Look to Asia for Innovation 

Life Science Investor Mandates (Sept. 23 - Oct. 1)

Seeking Early Stage Medical Devices

Seeking Medical Device Opportunities

Seeking Clinical Stage Therapeutics

LSN Videos
RESI Partnering Platform
[Book] The Life Science Executive's Fundraising Manifesto
Quick Links

Major Corporate Venture Funds Discuss Early Stage Investing 

By Nono Hu, Senior Manager, Branding & Messaging, LSN 


At the third Redefining Early Stage Investments (RESI) Conference, LSN brought together experts from six major corporate venture funds that are involved in the early stage life science arena. The speakers shared examples of their recent investments and detailed their investment interests. The panelists also answered a variety of questions, including: What is your take on the resurgence of early stage pharmaceutical investment? How should I approach a corporate VC investor? Do corporate venture funds outperform VC firms, large pharmas, and other sources of investment? What is your advice for scientist-entrepreneurs?


Click on the video link below to hear the views of major players in the life science industry

How to Identify Life Science Investors
By Michael Quigley, Director of Research, LSN


The research team at Life Science Nation is constantly identifying, interviewing, and profiling investors in the life science space. From Boston to Hong Kong, we leave no stone unturned in our efforts to uncover a variety of investors. This article shares some sources and tactics that we use to initially identify life science investors across the globe.


Investment Conferences: A great way to begin a search is by scouring the lists of attendees and speakers for various life science investment conferences. Investors who recently attended these types of events tend to be actively seeking new opportunities and therefore are ideal prospects for your campaign. With life science investment and partnering conferences taking place year-round and worldwide, there are a lot of potential investors to be uncovered...


Life Science Investors Look to Asia for Innovation

By Lucy Parkinson, Senior Research Manager, LSN 


At LSN, we track both life science companies and life science investors located all over the world. We frequently stress that if you're seeking capital in the life science field, you will have more success if you reach out beyond your own backyard and market your opportunity to global investors. Nowhere is this more apparent than in Asia, where a history of concentrated R&D funding has resulted in the flowering of new biotech start-ups in the region.

The LSN Company Platform tracks thousands of life science companies across Asia. As shown in Exhibit 1, some of these are contract research organizations, suppliers, and other outsourcing partners, but many are companies developing innovative biotechnology or medical technology products...

Address: 9B Hamilton Place, Boston, MA, 02108, USA

Phone: +1 (617) 600-0668

Email: [email protected]

follow us: Follow us on Twitter View our profile on LinkedIn  

Michael Quigley, Director of Research, LSN
Nono Hu, Senior Manager, Branding & Messaging, LSN